Articles & Videos

Condition-based content: what was checked, insights and source links.

All Research in One Place

2026-06-30

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project

What was examined: CONCLUSIONS: Wide cross-national inequalities exist in workforce capacity and reimbursed care for people with RMDs. RheumaFacts delivers the first harmonised basis for monitoring these gaps, enabling EULAR and national societies to track progress and inform health policy makers to advocate for improving the quality of life of people with RMDs.

Insight: open the full study on PubMed for complete details.

2026-04-23

The effect of IL-1 blockers on exertional leg pain in familial Mediterranean fever patients: an exploratory study

What was examined: CONCLUSION: IL-1 blockers provide meaningful benefit in approximately half of patients with FMF-related ELP, supporting their role as a therapeutic option for this refractory manifestation. However, the persistence of ELP in a substantial proportion of patients underscores the need for additional therapeutic strategies to address this disabling manifestation.

Insight: open the full study on PubMed for complete details.

2025-10-01

Acute Attack Treatment: Fast Anakinra Injection

What was examined: whether a single Kineret injection can stop an FMF attack.

Patient insight: a timely single Anakinra (Kineret) injection can stop the attack and significantly reduce pain and duration.

2025-10-01

Characteristics of Patients With Double V694M Mutations

What was examined: the health impact of double V694M mutation carriage.

Insight: homozygous patients have higher risk for severe disease, colchicine non-response, and complications; close monitoring is required.

2025-07-01

Plaquenil in Cutaneous Lupus

What was examined: whether early treatment prevents systemic lupus.

Insight: early treatment reduces risk of progression to systemic lupus.

2025-05-01

JAK Inhibitors and Risk of Intestinal Perforation

What was examined: whether there is risk for intestinal perforation.

Insight: increased reporting was found; in patients at risk for diverticular disease, treatment should be considered with caution.